Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young Adults

Author:

Gist Katja M.1,Menon Shina2,Anton-Martin Pilar3,Bigelow Amee M.4,Cortina Gerard5,Deep Akash6,De la Mata-Navazo Sara7,Gelbart Ben8,Gorga Stephen9,Guzzo Isabella10,Mah Kenneth E.11,Ollberding Nicholas J.1,Shin H. Stella12,Thadani Sameer13,Uber Amanda1415,Zang Huaiyu1,Zappitelli Michael16,Selewski David T.17, ,Ahern Emily18,Akcan Arikan Ayse18,Alhamoud Issa18,Alobaidi Rashid18,Balani Shanthi S18,Barhight Matthew18,Basalely Abby18,Bottari Gabriella18,Cappoli Andrea18,Ciccia Eileen A18,Collins Michaela18,Colosimo Denise18,Damian Mihaela A18,DeAbreu Gabrielle18,Ding Kathy L18,Dolan Kristin J18,Fernandez LaFever Sarah N18,Fuhrman Dana Y18,Guzzi Francesco18,Haga Taiki18,Harvey Elizabeth18,Hasson Denise C18,Hill-Horowitza Taylor18,Inthavong Haleigh18,Joseph Catherine18,Kaddourah Ahmad18,Kakajiwala Aadil18,Kessel Aaron D18,Korn Sarah18,Krallman Kelli A18,Kwiatkowski David M18,Lee Jasmine18,Lequier Laurance18,Madani Kia Tina18,Marinari Eleonora18,Martin Susan D18,Mohamed Tahagod H18,Morgan Catherine18,Mottes Theresa18,Muff-Luett Melissa A18,Namachivayam Siva18,Neumayr Tara M18,Nhan Jennifer18,O'Rourke Abigail18,Pinto Matthew G18,Qutob Dua18,Raggi Valeria18,Reynaud Stephanie18,Ricci Zaccaria18,Rumlow Zachary A18,Santiago Lozano María J18,See Emily18,Serpe Carmela18,Serratore Alyssa18,Shah Ananya18,Shih Weiwen V18,Slagle Cara L18,Solomon Sonia18,Soranno Danielle E18,Srivastava Rachana18,Stanski Natalja L18,Starr Michelle C18,Stenson Erin K18,Strong Amy E18,Taylor Susan A18,Van Wyk Brynna18,Webb Tennille N18,Zangla Emily E18

Affiliation:

1. Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio

2. Seattle Children’s Hospital, University of Washington, Seattle

3. Children’s Hospital Philadelphia, Philadelphia, Pennsylvania

4. Nationwide Children’s Hospital, The Ohio State University College of Medicine, Columbus

5. Medical University of Innsbruck, Innsbruck, Austria

6. King’s College Hospital, London, England

7. Gregorio Marañón University Hospital; Gregorio Marañón Health Research Institute, Madrid, Spain

8. Royal Children’s Hospital, University of Melbourne, Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

9. University of Michigan Medical School, C.S. Mott Children’s Hospital, Ann Arbor

10. Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

11. Stanford University School of Medicine, Palo Alto, California

12. Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia

13. Baylor College of Medicine, Texas Children’s Hospital, Houston

14. University of Nebraska Medical Center, Children’s Hospital & Medical Center, Omaha

15. University of Utah, Primary Children’s Hospital, Salt Lake City

16. Hospital for Sick Children, Toronto, Ontario, Canada

17. Medical University of South Carolina, Charleston

18. for the WE-ROCK Investigators

Abstract

ImportanceIn clinical trials, the early or accelerated continuous renal replacement therapy (CRRT) initiation strategy among adults with acute kidney injury or volume overload has not demonstrated a survival benefit. Whether the timing of initiation of CRRT is associated with outcomes among children and young adults is unknown.ObjectiveTo determine whether timing of CRRT initiation, with and without consideration of volume overload (VO; <10% vs ≥10%), is associated with major adverse kidney events at 90 days (MAKE-90).Design, Setting, and ParticipantsThis multinational retrospective cohort study was conducted using data from the Worldwide Exploration of Renal Replacement Outcome Collaborative in Kidney Disease (WE-ROCK) registry from 2015 to 2021. Participants included children and young adults (birth to 25 years) receiving CRRT for acute kidney injury or VO at 32 centers across 7 countries. Statistical analysis was performed from February to July 2023.ExposureThe primary exposure was time to CRRT initiation from intensive care unit admission.Main Outcomes and measuresThe primary outcome was MAKE-90 (death, dialysis dependence, or persistent kidney dysfunction [>25% decline in estimated glomerular filtration rate from baseline]).ResultsData from 996 patients were entered into the registry. After exclusions (n = 27), 969 patients (440 [45.4%] female; 16 (1.9%) American Indian or Alaska Native, 40 (4.7%) Asian or Pacific Islander, 127 (14.9%) Black, 652 (76.4%) White, 18 (2.1%) more than 1 race; median [IQR] patient age, 8.8 [1.7-15.0] years) with data for the primary outcome (MAKE-90) were included. Median (IQR) time to CRRT initiation was 2 (1-6) days. MAKE-90 occurred in 630 patients (65.0%), of which 368 (58.4%) died. Among the 601 patients who survived, 262 (43.6%) had persistent kidney dysfunction. Of patients with persistent dysfunction, 91 (34.7%) were dependent on dialysis. Time to CRRT initiation was approximately 1 day longer among those with MAKE-90 (median [IQR], 3 [1-8] days vs 2 [1-4] days; P = .002). In the generalized propensity score–weighted regression, there were approximately 3% higher odds of MAKE-90 for each 1-day delay in CRRT initiation (odds ratio, 1.03 [95% CI, 1.02-1.04]).Conclusions and RelevanceIn this cohort study of children and young adults receiving CRRT, longer time to CRRT initiation was associated with greater risk of MAKE-90 outcomes, in particular, mortality. These findings suggest that prospective multicenter studies are needed to further delineate the appropriate time to initiate CRRT and the interaction between CRRT initiation timing and VO to continue to improve survival and reduce morbidity in this population.

Publisher

American Medical Association (AMA)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3